Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity
Kristin E. Claflin, Andrew I. Sullivan, Meghan C. Naber, et al.
Molecular Metabolism (2022) Vol. 64, pp. 101564-101564
Open Access | Times Cited: 20

Showing 20 citing articles:

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
Alexandra S. Aaldijk, Cristy R.C. Verzijl, Johan W. Jonker, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 25
Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets
Thao D. V. Le, Payam A. Fathi, Amanda B. Watters, et al.
Molecular Metabolism (2023) Vol. 72, pp. 101718-101718
Open Access | Times Cited: 22
The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response
Jayashree Jena, Luis Miguel García-Peña, Renata O. Pereira
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
FGF21 Induces Skeletal Muscle Atrophy and Increases Amino Acids in Female Mice: A Potential Role for Glucocorticoids
Karlton R. Larson, Devi Jayakrishnan, Karla A. Soto Sauza, et al.
Endocrinology (2024) Vol. 165, Iss. 3
Closed Access | Times Cited: 6
Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
Shuo Li, Tiande Zou, Jun Chen, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101064-101064
Open Access | Times Cited: 15
Prolonged FGF21 treatment increases energy expenditure and induces weight loss in obese mice independently of UCP1 and adrenergic signaling
Sara Stanić, Kristina Bardová, Petra Janovská, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116042-116042
Open Access | Times Cited: 4
Unlocking the Potential of Receptor-Based Approaches in Diabetes Treatment
Mohsina Patwekar, Faheem Patwekar, J. Pavan Kumar, et al.
BIO Integration (2025) Vol. 6, Iss. 1
Open Access
Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis
Malte Hasle Nielsen, Matthew P. Gillum, Niels Vrang, et al.
AJP Gastrointestinal and Liver Physiology (2023) Vol. 324, Iss. 5, pp. G378-G388
Open Access | Times Cited: 12
Higher levels of serum α-Klotho are longitudinally associated with less central obesity in girls experiencing weight gain
Gemma Carreras‐Badosa, Elsa Puerto‐Carranza, Berta Mas‐Parés, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11
Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids
Matteo Fiorenza, Antonio Checa, Rasmus M. Sandsdal, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101629-101629
Open Access | Times Cited: 3
Rare predicted loss of function alleles in Bassoon (BSN) are associated with obesity
Na Zhu, Charles A. LeDuc, Ilene Fennoy, et al.
npj Genomic Medicine (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Characterization of FGF21 Sites of Production and Signaling in Mice
Andrew I. Sullivan, Sharon O. Jensen-Cody, Kristin E. Claflin, et al.
Endocrinology (2024) Vol. 165, Iss. 11
Closed Access | Times Cited: 2
Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
Lucas Zangerolamo, Marina Carvalho, Lı́cio A. Velloso, et al.
European Journal of Pharmacology (2023) Vol. 963, pp. 176248-176248
Closed Access | Times Cited: 5
FGF21 mediating sex dependent response to dietary macronutrients
Karla A. Soto Sauza, Karen K. Ryan
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 9, pp. e1689-e1696
Closed Access | Times Cited: 1
Tgr5 −/− mice are protected from ethanol-induced metabolic alterations through enhanced leptin and Fgf21 signaling
Sabita Pokhrel, Matthew Dilts, Zachary Stahl, et al.
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 3
Liver Fibroblast Growth Factor 21 (FGF21) is Required for the Full Anorectic Effect of the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide in Male Mice fed High Carbohydrate Diets
Thao D. V. Le, Payam A. Fathi, Amanda B. Watters, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Insights into the role of FGF21 in coronary heart disease
Qin-Yao Zhang, Hui‐Xin Liu
International Journal of Biological Macromolecules (2024), pp. 136911-136911
Closed Access
FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgery
Marie Patt, Isabel Karkossa, Laura Krieg, et al.
EBioMedicine (2024) Vol. 110, pp. 105458-105458
Open Access
Predicted loss of function alleles in Bassoon (BSN) are associated with obesity
Na Zhu, Charles A. LeDuc, Ilene Fennoy, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Hepatocellular carcinoma induced by hepatocyte Pten deletion reduces BAT UCP-1 and thermogenic capacity in mice, despite increasing serum FGF-21 and iWAT browning
Álbert S. Peixoto, Mayara Franzoi Moreno, Érique Castro, et al.
Journal of Physiology and Biochemistry (2023) Vol. 79, Iss. 4, pp. 731-743
Closed Access
Page 1

Scroll to top